Your session is about to expire
← Back to Search
Other
Acoustical Resonance Device for Infant Hip Disorders
N/A
Recruiting
Led By Pablo Castaneda, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study visit 1 (day 1)
Awards & highlights
Study Summary
This trial will help doctors design a way to diagnose DDH earlier.
Eligible Conditions
- Developmental Dysplasia of the Hip
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study visit 1 (day 1)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study visit 1 (day 1)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Difference in soundwaves on the Actuator on greater trochanter, sensor on anterior superior iliac crest
Sacral Region
Difference in soundwaves on the Actuator on patella, sensor on anterior superior iliac crest of pelvis
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Infants with developmental dysplasia of the hipExperimental Treatment1 Intervention
Infant participants putting on a device for 15 minutes to take different measurements of the hip
Group II: Infants without developmental dysplasia of the hipActive Control1 Intervention
Infant participants putting on a device for 15 minutes to take different measurements of the hip
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,631 Total Patients Enrolled
University of Central FloridaOTHER
78 Previous Clinical Trials
1,097,386 Total Patients Enrolled
Pablo Castaneda, MDPrincipal InvestigatorNYU Lagone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Only infants who are older than six months can participate.Babies who are not alive or whose chances of survival are uncertain.Babies who were born too early.Both baby boys and girls can participate.
Research Study Groups:
This trial has the following groups:- Group 1: Infants with developmental dysplasia of the hip
- Group 2: Infants without developmental dysplasia of the hip
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger